UBS AM’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-70,150
Closed -$224K 2650
2024
Q4
$224K Buy
70,150
+11,472
+20% +$36.6K ﹤0.01% 2631
2024
Q3
$783K Buy
58,678
+3,211
+6% +$42.9K ﹤0.01% 2495
2024
Q2
$553K Buy
+55,467
New +$553K ﹤0.01% 2603